Locked nucleic acid hybrids and methods of use
View Patent ↗The invention relates to methods for inhibiting, cloning, modifying or labelling an endogenous DNA sequence using compositions comprising recombinases in combination with exogenous polynucleotides containing “anchoring” or “locking” sequences. The anchoring sequences serve to stabilize structures formed by the exogenous polynucleotides and the endogenous DNA. The stabilized structure thus can either serve to regulate gene transcription or replication, or can allow the endogenous sequences to be labelled or pulled out, i.e. cloned, or modified.
1. A composition comprising a double D-loop, said double-D loop comprising:
a target nucleic acid;
a first single stranded targeting polynucleotide comprising: a central region and two flanking regions which flank the central region of said first single stranded targeting polynucleotide and which form homology clamps with said target nucleic acid;
a second single stranded targeting polynucleotide comprising: a central region and two flanking regions which flank the central region of said second single stranded targeting polynucleotide and which form homology clamps with said target nucleic acid; and
a locking complex formed by the central regions of said first and said second single stranded polynucleotides,
wherein said locking complex is a triplex or a quadruplex.
2. A composition comprising a double D-loop, said double D loop comprising:
a target nucleic acid;
a first single stranded targeting polynucleotide comprising: a central region and two flanking regions which flank the central region of said first single stranded targeting polynucleotide and which form homology clamps with said target nucleic acid;
a second single stranded targeting polynucleotide comprising: a central region and two flanking regions which flank the central region of said second single stranded targeting polynucleotide and which form homology clamps with said target nucleic acid; and
a locking complex formed by the central regions of said first and said second single stranded polynucleotides,
wherein said locking complex comprises a quadruplex.
3. A composition comprising a double D-loop, said double D loop comprising:
a target nucleic acid;
a first single stranded targeting polynucleotide comprising: a central region and two flanking regions which flank the central region of said first single stranded targeting polynucleotide and which form homology clamps with said target nucleic acid;
a second single stranded targeting polynucleotide comprising: a central region and two flanking regions which flank the central region of said second single stranded targeting polynucleotide and which form homology clamps with said target nucleic acid; and
a locking complex formed by the central regions of said first and said second single stranded polynucleotides,
wherein said locking complex comprises Z-form duplex.
4. A composition comprising a double D-loop, said double D loop comprising:
a target nucleic acid;
a first single stranded targeting polynucleotide comprising: a central region and two flanking regions which flank the central region of said first single stranded targeting polynucleotide and which form homology clamps with said target nucleic acid;
a second single stranded targeting polynucleotide comprising: a central region and two flanking regions which flank the central region of said second single stranded targeting polynucleotide and which form homology clamps with said target nucleic acid; and
a locking complex formed by the central regions of said first and said second single stranded polynucleotides,
wherein said locking complex comprises a triplex.
5. The composition of claim 4 further comprising a secondary polynucleotide that stabilizes said triplex.
6. A composition comprising a double D-loop comprising a target nucleic acid and a first and a second single stranded targeting polynucleotide, wherein said first and said second targeting polynucleotides are substantially complementary to each other and further wherein said first and said second targeting polynucleotides each comprise:
a first and second homology clamp wherein said first and said second homology clamps substantially correspond to or are substantially complementary to a preselected target nucleic acid sequence; and
a locking nucleic acid sequence positioned between said first and said second homology clamps wherein said locking nucleic acid sequence is capable of stabilizing a locking complex in a double D-loop structure, wherein said locking complex is a triplex or a quadruplex.
7. The composition according to claim 6 further comprising at least one recombinase.
8. The composition according to claim 6 further comprising a protein bound to said locking complex.
9. A composition comprising a double D-loop, said double-D loop comprising:
a target nucleic acid;
a first single stranded targeting polynucleotide comprising: a central region and two flanking regions which flank the central region of said first single stranded targeting polynucleotide and which form homology clamps with said target nucleic acid;
a second single stranded targeting polynucleotide comprising: a central region and two flanking regions which flank the central region of said second single stranded targeting polynucleotide and which form homology clamps with said target nucleic acid; and
a locking complex formed by the central regions of said first and said second single stranded polynucleotides,
wherein said locking complex comprises at least one non-Watson-Crick base pair.
10. The composition according to any one of claims 1 , 4 , 2 , 3 or 9 , wherein said locking complex comprises DNA, RNA or peptide nucleic acid.
11. The composition according to any one of claims 1 , 4 , 2 , 3 or 9 , wherein at least one of said single stranded targeting polynucleotides is linked to at least one protein substituent.
12. The composition according to any one of claims 1 , 4 , 2 , 3 or 9 , wherein at least one of said single stranded targeting polynucleotides is linked to at least one non-protein chemical substituent.
13. The composition of claim 12 wherein said substituent is selected from the group consisting of intercalators, cross-linking moieties, labels, photoactive moieties, nucleic acid scission inducing moieties, purification tag moieties, and nucleic acid modification moieties.
14. A cell comprising a composition according to any one of claims 1 , 4 , 2 , 3 or 9 .
15. The cell of claim 14 which is a eukaryotic cell.
16. The cell of claim 14 which is a prokaryotic cell.
17. A composition according to any one of claims 1 , 4 , 2 , 3 or 9 , further comprising at least one recombinase.
18. The composition of claim 17 wherein said recombinase is a species of prokaryotic recombinase.
19. The composition of claim 18 , wherein said prokaryotic recombinase is a species of prokaryotic RecA protein.
20. The composition of claim 19 , wherein said RecA protein species is E. coli RecA.
21. The composition of claim 17 , wherein said recombinase is a species of eukaryotic recombinase.
22. The composition of claim 21 , wherein said recombinase is a Rad51 recombinase.
23. The composition of claim 22 , wherein said eukaryotic recombinase is a complex of recombinase proteins.
24. A kit comprising a first and a second single stranded targeting polynucleotide, wherein said first and said second targeting polynucleotides are substantially complementary to each other and further wherein said first and said second targeting polynucleotides each comprise:
a first and a second homology clamp that wherein said first and said second homology clamps substantially correspond to or are substantially complementary to a preselected target nucleic acid sequence; and
a locking nucleic acid sequence positioned between said first and said second homology clamps wherein said locking nucleic acid sequence is capable of stabilizing a locking complex in a double D-loop structure, wherein said locking complex is a triplex or a quadruplex.
25. The kit according to claim 24 further comprising at least one recombinase.